The development and hosting of this resource hub has been commissioned by Roche Diagnostics Limited (Roche). This resource hub contains links to Guidelines and Guidelines in Practice independent educational content, clinical resources, and additional items from Roche, some of which may be promotional in nature.
Diagnostic Guidance supplement
This supplement reproduces the NICE recommendations from NICE Diagnostics Guidance 14.
- Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor)
The production and printing of this Diagnostic Guidance supplement has been funded by Roche Diagnostics. Roche Diagnostics has reviewed this supplement for technical accuracy and regulatory compliance.
An analysis by Heneghan C et al (Oxford University) showed that self-monitoring and self-management of oral coagulation is a safe option for suitable patients of all ages.
- Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data
By clicking on this link you will leave the Guidelines website. MGP Ltd does not accept responsibility for the content of third party websites.